Bone Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bone Biologics and other ETFs, options, and stocks.About BBLG
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration.
CEOJeffrey Frelick
CEOJeffrey Frelick
Employees2
Employees2
HeadquartersBurlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded2004
Founded2004
Employees2
Employees2
BBLG Key Statistics
Market cap2.94M
Market cap2.94M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume43.22K
Average volume43.22K
High today$1.66
High today$1.66
Low today$1.61
Low today$1.61
Open price$1.62
Open price$1.62
Volume14.29K
Volume14.29K
52 Week high$7.74
52 Week high$7.74
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
Bone Biologics(BBLG) stock is priced at $1.64, giving the company a market capitalization of 2.94M. It carries a P/E multiple of -0.24.
On 2026-01-14, Bone Biologics(BBLG) stock traded between a low of $1.61 and a high of $1.66. Shares are currently priced at $1.64, which is +1.8% above the low and -1.2% below the high.
Bone Biologics(BBLG) shares are trading with a volume of 14.29K, against a daily average of 43.22K.
During the past year, Bone Biologics(BBLG) stock moved between $1.30 at its lowest and $7.74 at its peak.
During the past year, Bone Biologics(BBLG) stock moved between $1.30 at its lowest and $7.74 at its peak.
People also own
Based on the portfolios of people who own BBLG. This list is generated using Robinhood data, and it’s not a recommendation.